Advertisement

Topics

Saul Ewing Company Profile

06:51 EDT 22nd September 2018 | BioPortfolio

At Saul Ewing, we are dedicated to the key values of excellence, energy and enthusiasm: excellence in our legal services, the energy to succeed, and an enthusiasm for understanding and being responsive to our clients' needs. These core values are the hallmarks of our more than eight decades of service to clients.

Location

Lockwood Place500 East Pratt Street, Suite 900
Baltimore
Maryland
21202-3171
United States of America

Contact

Phone: 410.332.8600
Fax: 410.332.8862


News Articles [34 Associated News Articles listed on BioPortfolio]

A potential new therapeutic target for Ewing sarcoma

(IDIBELL-Bellvitge Biomedical Research Institute) IDIBELL researchers correlate EphA2 membrane receptor with the metastatic capacity of tumors in Ewing sarcoma.Ewing sarcoma is the second most frequen...

Link between BRCA1 and Ewing sarcoma

Scientists have discovered a surprising connection between a breast cancer protein, BRCA1, and a pediatric cancer called Ewing sarcoma.

Ewing Sarcoma Epidemiology Forecast to 2027 [Report Updated: 14022018] Prices from USD $3250

DelveInsight's "Ewing Sarcoma Epidemiology Forecast, 2027 report provides a comprehensive analysis of the Ewing Sarcoma epidemiology, providing the historical and forecasted data for the 7MM during...

Mechanisms of action of key genetic abnormality in Ewing sarcoma

Medical researchers have used epigenome editing tools to investigate how the genetic abnormality that drives Ewing sarcoma -- the second most common bone cancer in children and young adults -- unleash...

Ewing Sarcoma Pipeline Review, H1 2018 – Therapeutics Development Analyzed, Key Companies Involved and Drug Profiles Covered – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ewing Sarcoma – Pipeline Review, H1 2018” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive...

Mechanisms of action of key genetic abnormality in Ewing sarcoma defined

A Massachusetts General Hospital (MGH) research team has used epigenome editing tools to investigate how the genetic abnormality that drives Ewing sarcoma - the second most common bone cancer in child...

Link between BRCA1 and Ewing sarcoma found

Scientists with the Greehey Children's Cancer Research Institute at UT Health San Antonio have discovered a surprising connection between a breast cancer protein, BRCA1, and a paediatric cancer called...

Researchers discover potential new therapeutic target for Ewing sarcoma

The sarcoma research group of the Bellvitge Biomedical Research Institute, led by Dr. Òscar Martínez-Tirado, has identified a potential new therapeutic target for Ewing sarcoma, the second most freq...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Cosmegen [Lundbeck Inc.]

Cosmegen for Injection (dactinomycin for injection) (Actinomycin D) Rx only

PubMed Articles [42 Associated PubMed Articles listed on BioPortfolio]

EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.

Ewing sarcoma is an aggressive paediatric cancer of the bone and soft tissue. It results from a chromosomal translocation, predominantly t(11;22)(q24:q12), that fuses the N-terminal transactivation do...

Molecular assessment of circulating exosomes toward liquid biopsy diagnosis of Ewing sarcoma family of tumors.

Ewing sarcoma was first described in 1921 in the Proceedings of the New York Pathological Society by an eminent American pathologist from Cornell named James R. Ewing as a "diffuse endothelioma of bon...

EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.

EWS-FLI1 constitutes an oncogenic transcription factor that plays key roles in Ewing sarcoma development and maintenance. We have recently succeeded in generating an ex vivo mouse model for Ewing sarc...

Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma.

The median age of patients with Ewing sarcoma (EwS) at diagnosis is around 14-15 years. Older age is associated with a worse outcome. The correlation of age at diagnosis on sites of disease has not be...

PAX7 Immunohistochemical Evaluation of Ewing Sarcoma and Other Small Round Cell Tumors.

Ewing sarcoma is a small round cell tumor that affects bone and soft tissues. Although the detection of the specific fusion gene is a robust method of its diagnosis, immunohistochemistry may serve as ...

Clinical Trials [61 Associated Clinical Trials listed on BioPortfolio]

Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma

Despite improvements in outcomes for patients with localized Ewing sarcoma, patients with relapsed metastatic Ewing sarcoma continue to have poor outcomes with current chemotherapy options...

TK216 in Patients With Relapsed or Refractory Ewing Sarcoma

Ewing sarcoma is characterized by genomic rearrangements resulting in over-expression of ets family transcription factors driving tumor progression. TK216 is designed to inhibit this effec...

Clinical Trial of SP-2577 in Patients With Relapsed or Refractory Ewing Sarcoma

Phase 1, open-label, non-randomized dose finding study of SP-2577 in patients with refractory or recurrent Ewing sarcoma.

Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors

This is a phase 1 study of anti-IGF-IR CP-751,871 in patients with solid tumors currently enrolling patients 9 years old and older with Ewing's sarcoma family of tumors (Ewing's, PNET and ...

Anlotinib and Irinotecan for Ewing Sarcoma

The investigators explored the activity of anlotinib combined with irinotecan in patients with relapsed and metastatic Ewing Sarcoma.

Companies [10 Associated Companies listed on BioPortfolio]

Saul Ewing

At Saul Ewing, we are dedicated to the key values of excellence, energy and enthusiasm: excellence in our legal services, the energy to succeed, and an enthusiasm for understanding and being responsiv...

Stringer Saul LLP

Stringer Saul LLP is a commercial law practice which has developed substantial legal capabilities in its practice areas and market expertise in certain industry sectors. We recognise that our clients ...

The iBridge Network

The iBridgeSM Network is a program of the Kauffman Innovation Network, Inc., an initiative of the Ewing Marion Kauffman Foundation. To learn more, please visit www.iBridgeNetwork....

1 Million 4 Anna Foundation

The 1 Million 4 Anna Foundation strives to further Anna’s legacy and embody her fighting spirit by winning the fight against Ewing’s Sarcoma today, tomorrow, and until i...

iBridge Network

The iBridge(SM) Network is an innovation catalyst with a vibrant, online community enabling universities, companies and entrepreneurs to connect, collaborate and license tomorrow's research, products ...

More Information about "Saul Ewing" on BioPortfolio

We have published hundreds of Saul Ewing news stories on BioPortfolio along with dozens of Saul Ewing Clinical Trials and PubMed Articles about Saul Ewing for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Saul Ewing Companies in our database. You can also find out about relevant Saul Ewing Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record